Therapeutic potential of mesenchymal stromal/stem cells in critical-care patients with systemic inflammatory response syndrome.
Gerardo-Javier Martí-ChillónSandra MuntiónSilvia PreciadoLika OsuguiAlmudena Navarro-BailónJavier González-RobledoVíctor SagredoJuan F BlancoFermin M Sanchez-GuijoPublished in: Clinical and translational medicine (2023)
In the current review, after briefly overviewing SIRS physiopathology, we explore the potential mechanisms why MSC therapy could aid in the recovery of this condition and the pre-clinical and early clinical evidence generated to date.